Svoboda | Graniru | BBC Russia | Golosameriki | Facebook

Cyclin-dependent kinase subunit (Cks) 1 or Cks2 overexpression overrides the DNA damage response barrier triggered by activated oncoproteins

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2754-9. doi: 10.1073/pnas.1102434108. Epub 2011 Jun 22.

Abstract

Cyclin-dependent kinase subunit (Cks) proteins are small cyclin-dependent kinase-interacting proteins that are frequently overexpressed in breast cancer, as well as in a broad spectrum of other human malignancies. However, the mechanistic link between Cks protein overexpression and oncogenesis is still unknown. In this work, we show that overexpression of Cks1 or Cks2 in human mammary epithelial and breast cancer-derived cells, as well as in other cell types, leads to override of the intra-S-phase checkpoint that blocks DNA replication in response to replication stress. Specifically, binding of Cks1 or Cks2 to cyclin-dependent kinase 2 confers partial resistance to the effects of inhibitory tyrosine phosphorylation mediated by the intra-S-phase checkpoint, allowing cells to continue replicating DNA even under conditions of replicative stress. Because many activated oncoproteins trigger a DNA damage checkpoint response, which serves as a barrier to proliferation and clonal expansion, Cks protein overexpression likely constitutes one mechanism whereby premalignant cells can circumvent this DNA damage response barrier, conferring a proliferative advantage under stress conditions, and therefore contributing to tumor development.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • CDC2-CDC28 Kinases
  • Carrier Proteins / metabolism*
  • Cell Cycle Proteins / metabolism*
  • Cell Line, Tumor
  • Cyclin-Dependent Kinases / metabolism*
  • DNA Damage*
  • HEK293 Cells
  • Humans
  • Hydroxyurea / pharmacology
  • Mice
  • Oncogene Proteins / metabolism*
  • Protein Kinases / metabolism*
  • S Phase / drug effects
  • Signal Transduction / drug effects
  • Thymidine / pharmacology

Substances

  • CKS1B protein, human
  • Carrier Proteins
  • Cell Cycle Proteins
  • Oncogene Proteins
  • Protein Kinases
  • CDC2-CDC28 Kinases
  • CKS2 protein, human
  • Cyclin-Dependent Kinases
  • Thymidine
  • Hydroxyurea